Details of the Drug Combinations

General Information of This Drug (ID: DM20LIM)

Drug Name

Bremelanotide DM20LIM

Synonyms

Bremelanotide (USAN/INN); PT-141; Rekynda

Indication

Disease Entry	ICD 11	Status	REF
Hypoactive sexual desire dysfunction	HA00	Approved	[1]
Erectile dysfunction	HA01.1	Phase 3	[2]
------------------------------------------------------------------------------------

Drug Type

Small molecular drug

Structure

3D MOL is unavailable

2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

1 Clinical Trial Drug Combination(s) Consisting of This drug

DrugCom Name	DrugCom ID	Component Drug	Indication	REF
Bremelanotide + Ondansetron	DCYVK4L	Ondansetron	Nausea	[3]
------------------------------------------------------------------------------------

References

1	Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health Human Services. 2019
2	Designing drugs for the treatment of female sexual dysfunction. Drug Discov Today. 2007 Sep;12(17-18):757-66.
3	ClinicalTrials.gov (NCT03973047) Study to Evaluate Rate of Nausea in Healthy Premenopausal Female Subjects Treated With Single Dose of Bremelanotide Alone or With Zofran